About the Company
ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS®), a ground-breaking technology being developed to visualize tissue like MRI, but at 1/50th the cost and at the point of patient care. TAEUS® is designed to work in concert with the over 1 million ultrasound systems in use globally today. TAEUS® is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and inflammation (NASH), chronic liver conditions that affect over 1 billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS®, including visualization of tissue temperature during energy-based surgical procedures.
Employees
18
Fundamental Data and Insider Transactions (Quarterly data) Full Screen
Loading the fundamentals chart...
Latest $NDRA News
ENDRA Life Sciences Inc (NDRA): A Technical Analysis
ENDRA Life Sciences Inc (NDRA) has experienced a -25.99% fall in stock performance for the past week, with a -74.81% drop in the past month, and a -79.85% drop in the past quarter. The volatility ...
Palisade Bio stock rallies on Strand Life Sciences partnership
Palisade Bio announced a strategic collaboration with Strand Life Sciences today. Palisade Bio stock opened a whopping 50% up ...
India's Glenmark Life Sciences posts lower Q4 profit as Red Sea crisis hurts API business
Indian drugmaker Glenmark Life Sciences posted its first drop in profit for six quarters on Thursday as its mainstay active ...
Palisade Bio Enters into Strategic Collaboration with Strand Life Sciences to Advance Precision Medicine Approach
The collaboration with Strand Life Sciences provides Palisade Bio access to advanced bioinformatics tools vital for understanding complex disease pathways and predicting responses to PDE4 inhibitors.
Loading the latest forecasts...